Cross Shawn
Chief Financial Officer at PCRX; CEO & Chair of the Board at Applied Molecular Transport Inc.
- Sold, on record
- $1.9M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Apr 23, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- PCRXPacira BioSciences, Inc.Chief Financial Officer
- Applied Molecular Transport Inc.CEO & Chair of the Board
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Applied Molecular Transport Inc.420,412 shares
- PCRX62,060 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Applied Molecular Transport Inc.No planSep 5, 2023 2023
Sold 5,559 shares at $0.23 ($1k)
Cross Shawn, CEO & Chair of the Board
No 10b5-1 planSold 0.7% of holdings ($175k position)746,748 shares left1.4x usual sizeFiling
- 2 Form 4 sale Applied Molecular Transport Inc.UnusualSep 29, 2023 +24 days
Sold 193,960 shares at $0.16 ($31k)
Cross Shawn, CEO & Chair of the Board
No 10b5-1 planSold 20.5% of holdings ($151k position)752,307 shares left80.4x usual sizeFiling
- 3 Form 4 sale Applied Molecular Transport Inc.UnusualNov 15, 2023 +47 days
Sold 90,447 shares at $0.16 ($14k)
Cross Shawn, CEO & Chair of the Board
No 10b5-1 planSold 12.1% of holdings ($119k position)656,301 shares left23.1x usual sizeFiling
- 4 Form 4 sale Applied Molecular Transport Inc.UnusualNov 22, 2023 +7 days
Sold 110,802 shares at $0.16 ($18k)
Cross Shawn, CEO & Chair of the Board
No 10b5-1 planSold 16.9% of holdings ($105k position)545,499 shares left28.2x usual sizeFiling
- 5 Form 4 sale PCRXRoutineNov 10, 2025 +719 days
Sold 12,060 shares at $22.09 ($266k)
Cross Shawn, Chief Financial Officer
10b5-1 planSold 17.7% of holdings ($1.5M position)56,250 shares leftFirst sale on recordFiling
- 6 Form 4 sale PCRXRoutineDec 10, 2025 +30 days
Sold 25,000 shares at $25.07 ($627k)
Cross Shawn, Chief Financial Officer
10b5-1 planSold 30.8% of holdings ($2M position)56,250 shares leftFiling
- 7 Form 4 sale PCRXRoutineApr 22, 2026 +133 days
Sold 12,059 shares at $25.09 ($303k)
Cross Shawn, Chief Financial Officer
10b5-1 planSold 10.3% of holdings ($2.9M position)105,341 shares leftFiling
- 8 Form 4 sale PCRXRoutineApr 23, 2026 +1 day
Sold 12,941 shares at $25.16 ($326k)
Cross Shawn, Chief Financial Officer
10b5-1 planSold 10.9% of holdings ($3M position)105,341 shares left1.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Apr 24, 2026 | PCRX | Chief Financial Officer | Form 4 sale | 12,941 | $326k | 10.9% | Routine | SEC |
| Apr 22, 2026 | Apr 22, 2026 | PCRX | Chief Financial Officer | Form 4 sale | 12,059 | $303k | 10.3% | Routine | SEC |
| Dec 10, 2025 | Dec 11, 2025 | PCRX | Chief Financial Officer | Form 4 sale | 25,000 | $627k | 30.8% | Routine | SEC |
| Nov 10, 2025 | Nov 13, 2025 | PCRX | Chief Financial Officer | Form 4 sale | 12,060 | $266k | 17.7% | Routine | SEC |
| Nov 22, 2023 | Nov 24, 2023 | Applied Molecular Transport Inc. | CEO & Chair of the Board | Form 4 sale | 110,802 | $18k | 16.9% | Unusual | SEC |
| Nov 15, 2023 | Nov 16, 2023 | Applied Molecular Transport Inc. | CEO & Chair of the Board | Form 4 sale | 90,447 | $14k | 12.1% | Unusual | SEC |
| Sep 29, 2023 | Oct 2, 2023 | Applied Molecular Transport Inc. | CEO & Chair of the Board | Form 4 sale | 193,960 | $31k | 20.5% | Unusual | SEC |
| Sep 5, 2023 | Oct 4, 2023 | Applied Molecular Transport Inc. | CEO & Chair of the Board | Form 4 sale | 5,559 | $1k | 0.7% | No plan | SEC |
| Mar 1, 2023 | Mar 3, 2023 | Applied Molecular Transport Inc. | President & COO | Form 4 sale | 934 | $467 | 1.5% | Plan not stated | SEC |
| Dec 2, 2022 | Dec 6, 2022 | Applied Molecular Transport Inc. | President & COO | Form 4 sale | 3,893 | $4k | 6.0% | Plan not stated | SEC |
| Sep 1, 2022 | Sep 6, 2022 | Applied Molecular Transport Inc. | President & COO | Form 4 sale | 884 | $1k | 1.3% | Plan not stated | SEC |
| Jun 2, 2022 | Jun 3, 2022 | Applied Molecular Transport Inc. | President & COO | Form 4 sale | 3,933 | $12k | 5.6% | Plan not stated | SEC |
| Aug 23, 2021 | Aug 23, 2021 | Applied Molecular Transport Inc. | Chief Financial Officer | Form 4 sale | 10,000 | $301k | 100.0% | Unusual | SEC |